The verdict
Our read at a glance.
Whether the natural exercise biology of MGF supports the muscle-building claims made for injected PEG-MGF gray-market products.
- The signal
- Research shows muscle naturally produces MGF, a form of IGF-1, after exercise and injury, and laboratory and animal work links it to muscle repair. There are no human trials showing that injecting PEG-MGF builds muscle, and it is not approved for any use.
- The unknown
- Whether injecting synthetic PEG-MGF does anything like the natural signal, and whether it is safe, neither of which has been tested in people.
- Our read
- Real exercise biology, no human evidence for the injectable product. MGF is a genuine muscle signal released during exercise, but there are no human trials of injecting PEG-MGF, so the muscle claims for gray-market products are unproven.
The mechanism
How it works.
MGF (mechano growth factor) is a splice variant of the IGF-1 gene that muscle produces in response to mechanical stress and damage, identical in concept to a local "start repair" signal released by exercise. In laboratory and animal work this peptide helps activate satellite cells, the muscle stem cells that fuse to fibers to rebuild them. PEG-MGF is a synthetic copy with a polyethylene glycol chain attached to slow its breakdown, and it is sold on the premise that injecting it reproduces that natural repair signal, but no human trial has tested whether injected PEG-MGF does anything of the kind.
Safety & regulatory boundary
The consequential part.
PEG-MGF is not an approved drug and has not been tested in published human trials. It is sold as a research chemical, where product identity and quality are uncertain. The natural exercise biology of MGF does not establish that injecting a synthetic version builds muscle or is safe, and gray-market products are not a studied preparation.
What's next
What we're watching.
Whether any controlled human trials of synthetic MGF are conducted, and any safety data.
Context
Why this is discussed.
MGF is appealing because it is a natural muscle-repair signal released during exercise, which the gray market frames as a basis for injecting synthetic PEG-MGF to build muscle.
The evidence base
20 cited references.
Registered trials8
ClinicalTrials.gov · PHASE3 · NOT_YET_RECRUITING · 2026-06-15
ClinicalTrials.gov · PHASE4 · RECRUITING · 2025-10-09
ClinicalTrials.gov · NA · COMPLETED · 2026-04-13
ClinicalTrials.gov · PHASE3 · RECRUITING · 2025-11-26
ClinicalTrials.gov · PHASE3 · COMPLETED · 2019-05-20
ClinicalTrials.gov · RECRUITING · 2020-11-23
ClinicalTrials.gov · NA · RECRUITING · 2026-01-01
ClinicalTrials.gov · PHASE2 · COMPLETED · 2022-02-18
Indexed literature (PubMed)12
Fink J et al. · Phys Sportsmed · 2018
Montúfar C et al. · Growth Horm IGF Res · 2018
Matonti L et al. · Minerva Pediatr · 2020
Li K et al. · Int J Biol Sci · 2023
Keating GM · BioDrugs · 2008
Nat Rev Dis Primers · Nat Rev Dis Primers · 2019
Cardoso LM et al. · Vitam Horm · 2026
Yan J et al. · Calcif Tissue Int · 2018
Higashi Y et al. · Growth Horm IGF Res · 2019
Hjelholt A et al. · Endocrinol Metab Clin North Am · 2020
Frater J et al. · Ageing Res Rev · 2018
Tang JJ et al. · Mol Brain · 2017
Keep reading